EUVIMEDEUVIMED entdecken
Crossref

Epigenetic modifications in hepatocellular carcinoma: A literature review

Taufik Sungkar, Darmadi Darmadi, Cennikon Pakpahan, Adriansyah Lubis

Rawal Medical Journal · 2025 · 50 (2) · 514

DOI: 10.5455/rmj.20240425033740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rawal Medical Journal, 2025. Verfasst von Taufik Sungkar und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the epigenetic mechanisms has opened new avenues for the potential reversibility of epigenetic alterations and provided an opportunity to influence and control their unfavorable consequences. These findings not only aid in identifying novel targets for therapy but also enable the prediction of treatment response. Investigating epigenetics can uncover new targets for more effective therapeutic strategies and identify novel biomarkers for diagnosing HCC in the future.

Zitieren

APA

Sungkar, T., Darmadi, D., Pakpahan, C., & Lubis, A. (2025). Epigenetic modifications in hepatocellular carcinoma: A literature review. Rawal Medical Journal, 50(2), 514. https://doi.org/10.5455/rmj.20240425033740

Vancouver

Sungkar T, Darmadi D, Pakpahan C, Lubis A. Epigenetic modifications in hepatocellular carcinoma: A literature review. Rawal Medical Journal. 2025;50(2):514. doi:10.5455/rmj.20240425033740

BibTeX
@article{Sungkar2025,
  author = {Sungkar, Taufik and Darmadi, Darmadi and Pakpahan, Cennikon and Lubis, Adriansyah},
  title = {Epigenetic modifications in hepatocellular carcinoma: A literature review},
  journal = {Rawal Medical Journal},
  year = {2025},
  volume = {50},
  number = {2},
  pages = {514},
  doi = {10.5455/rmj.20240425033740}
}
Kostenlos starten →